PMDA drug package insert
スタディーAG
PMDA OTC drug · スギ薬局 · package insert Sep 28, 2026
Key facts
| Brand names | スタディーAG |
|---|---|
| Companies | 製造販売元／キョーリンリメディオ（株）,販売会社／スギ薬局 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 液剤 |
| OTC effect category | 一般点眼薬 |
| Package insert date | Sep 28, 2026 |
| PMDA document key | 480209_J0601012845 |
| PMDA company code | 480209 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: